BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32256050)

  • 21. Cerebellin-2 promotes endothelial-mesenchymal transition in hypoxic pulmonary hypertension rats by activating NF-κB/HIF-1α/Twist1 pathway.
    Wang EL; Zhang JJ; Luo FM; Fu MY; Li D; Peng J; Liu B
    Life Sci; 2023 Sep; 328():121879. PubMed ID: 37355224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.
    Nie X; Wu Z; Shang J; Zhu L; Liu Y; Qi Y
    Eur J Pharmacol; 2023 Mar; 943():175546. PubMed ID: 36706802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
    Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction.
    de Raaf MA; Schalij I; Gomez-Arroyo J; Rol N; Happé C; de Man FS; Vonk-Noordegraaf A; Westerhof N; Voelkel NF; Bogaard HJ
    Eur Respir J; 2014 Jul; 44(1):160-8. PubMed ID: 24791833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnesium lithospermate B ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and its potential targets.
    Wang Y; Duo D; Yan Y; He R; Wu X
    Biomed Pharmacother; 2020 Oct; 130():110560. PubMed ID: 34321157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.
    Happé CM; de Raaf MA; Rol N; Schalij I; Vonk-Noordegraaf A; Westerhof N; Voelkel NF; de Man FS; Bogaard HJ
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1088-97. PubMed ID: 27036867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition.
    Zhang H; Lin Y; Ma Y; Zhang J; Wang C; Zhang H
    Int J Mol Med; 2019 Dec; 44(6):2091-2102. PubMed ID: 31573044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
    Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detrimental Impact of Vasopressin V2 Receptor Antagonism in a SU5416/Hypoxia/Normoxia-Exposed Rat Model of Pulmonary Arterial Hypertension.
    Goto I; Dohi K; Ogihara Y; Okamoto R; Yamada N; Mitani Y; Ito M
    Circ J; 2016; 80(4):989-97. PubMed ID: 26924211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model.
    Zhao C; Le X; Li M; Hu Y; Li X; Chen Z; Hu G; Hu L; Li Q
    Respir Res; 2023 Nov; 24(1):289. PubMed ID: 37978368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial-to-mesenchymal transition in pulmonary hypertension.
    Ranchoux B; Antigny F; Rucker-Martin C; Hautefort A; Péchoux C; Bogaard HJ; Dorfmüller P; Remy S; Lecerf F; Planté S; Chat S; Fadel E; Houssaini A; Anegon I; Adnot S; Simonneau G; Humbert M; Cohen-Kaminsky S; Perros F
    Circulation; 2015 Mar; 131(11):1006-18. PubMed ID: 25593290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition.
    Huang J; Lu W; Ouyang H; Chen Y; Zhang C; Luo X; Li M; Shu J; Zheng Q; Chen H; Chen J; Tang H; Sun D; Yuan JX; Yang K; Wang J
    Am J Respir Cell Mol Biol; 2020 Jan; 62(1):49-60. PubMed ID: 31211918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of miR-204 attenuates endothelial-mesenchymal transition by enhancing autophagy in hypoxia-induced pulmonary hypertension.
    Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP
    Eur J Pharmacol; 2019 Nov; 863():172673. PubMed ID: 31542480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition.
    Shi R; Zhu D; Wei Z; Fu N; Wang C; Liu L; Zhang H; Liang Y; Xing J; Wang X; Wang Y
    Life Sci; 2018 Aug; 207():442-450. PubMed ID: 29969608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Bruton's Tyrosine Kinase Alleviates Monocrotaline-Induced Pulmonary Arterial Hypertension by Modulating Macrophage Polarization.
    Yu M; Wu X; Peng L; Yang M; Zhou H; Xu J; Wang J; Wang H; Xie W; Kong H
    Oxid Med Cell Longev; 2022; 2022():6526036. PubMed ID: 36071873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baicalin attenuates pulmonary vascular remodeling by inhibiting calpain-1 mediated endothelial-to-mesenchymal transition.
    Jiang HX; Wang XD; Wang HX; Liu T
    Heliyon; 2023 Dec; 9(12):e23076. PubMed ID: 38144352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Injury-Induced Shedding of Extracellular Vesicles Depletes Endothelial Cells of Cav-1 (Caveolin-1) and Enables TGF-β (Transforming Growth Factor-β)-Dependent Pulmonary Arterial Hypertension.
    Oliveira SDS; Chen J; Castellon M; Mao M; Raj JU; Comhair S; Erzurum S; Silva CLM; Machado RF; Bonini MG; Minshall RD
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1191-1202. PubMed ID: 30943774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
    Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.